Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea

Claudia Brogna, Paolo Mariotti, Raffaele Manna*

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaEditorialepeer review

12 Citazioni (Scopus)

Abstract

Chorea is the most common movement disorder associated to autoimmune diseases and one of the first non thrombotic neurological complications associated with antiphospholipid antibodies (aPL). Several treatment options have been considered, especially in young patients that failed to respond to conventional therapy. In the last years Intravenous immunoglobulin treatment (IVIG) are largely administered with beneficial and rapid effect not only in adult patients affected by autoimmune diseases, but also in children. IVIG treatment could be considered as therapeutic option also in children with antiphospholipid related chorea.
Lingua originaleInglese
pagine (da-a)1449-1451
Numero di pagine3
RivistaLupus
Volume23
Numero di pubblicazione14
DOI
Stato di pubblicazionePubblicato - 2014
Pubblicato esternamente

All Science Journal Classification (ASJC) codes

  • Reumatologia

Keywords

  • chorea
  • immunoglobulin

Fingerprint

Entra nei temi di ricerca di 'Conventional and intravenous immunoglobulin therapy in paediatric antiphospholipid antibodies-related chorea'. Insieme formano una fingerprint unica.

Cita questo